Incidence and Risk Factors for Acute Kidney Injury after Allogeneic Stem Cell Transplantation: A Prospective Study.

acute kidney injury calcineurin inhibitors myeloablative stem cell transplantation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
25 Jan 2022
Historique:
received: 26 12 2021
revised: 14 01 2022
accepted: 24 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

(1) Background: Acute kidney injury (AKI) is a serious complication of hematopoietic stem cell transplantation (HSCT). (2) Methods: The aim was to identify the incidence, severity, and risk factors for AKI during the first 100 days after allo-HSCT; we performed a prospective observational study on 135 consecutive patients. (3) Results: The mean age was 38.3 ± 11.9 years (50.6% females), AKI developed in 93 patients (68.9%), the median time of appearance was 28 days, and the mean serum creatinine at the time of AKI was 1.8 ± 0.8 mg/dL. A total of 36 (38.7%) patients developed stage 1 AKI, 33 (35.5%) patients developed stage 2, and 24 (25.8%) patients developed stage 3; eight (8.6%) patients required temporary hemodialysis, and the mortality rate in these patients was 87.5%. Death was twice as frequent in the AKI subgroup, without statistical significance. Cyclosporine overdose (HR = 2.36, 95% CI: 1.45-3.85,

Identifiants

pubmed: 35203472
pii: biomedicines10020262
doi: 10.3390/biomedicines10020262
pmc: PMC8869231
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Sci Rep. 2019 Dec 30;9(1):20260
pubmed: 31889082
Transplantation. 1985 Sep;40(3):249-53
pubmed: 3898489
Strahlenther Onkol. 2005 Nov;181(11):704-8
pubmed: 16254705
Br J Haematol. 2020 Jun;189(6):1171-1181
pubmed: 32124435
Curr Opin Crit Care. 2014 Dec;20(6):588-95
pubmed: 25320909
Am J Kidney Dis. 2018 Dec;72(6):857-865
pubmed: 30146419
Biol Blood Marrow Transplant. 2019 Jan;25(1):137-144
pubmed: 30081073
Kidney Int. 2016 Sep;90(3):610-26
pubmed: 27470679
Haematologica. 2021 Aug 12;:
pubmed: 34382386
Lab Invest. 2011 Jun;91(6):837-51
pubmed: 21383672
Kidney Int. 2019 Nov;96(5):1083-1099
pubmed: 31443997
Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):711-726
pubmed: 28951581
N Engl J Med. 2016 Jun 9;374(23):2256-67
pubmed: 27276563
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Cancer Med. 2019 Jun;8(6):3278-3285
pubmed: 31016881
QJM. 2020 Sep 1;113(9):621-632
pubmed: 32101318
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
N Engl J Med. 2017 May 4;376(18):1770-1781
pubmed: 28467867
Front Immunol. 2021 Jan 29;11:619564
pubmed: 33633738
Biol Blood Marrow Transplant. 2009 Jan;15(1):21-9
pubmed: 19135939
Biol Blood Marrow Transplant. 2019 Oct;25(10):1920-1924
pubmed: 31271886
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):289-297
pubmed: 31836598
Kidney Int. 2005 Jan;67(1):272-7
pubmed: 15610251
Blood. 2005 Oct 15;106(8):2912-9
pubmed: 15994282
Front Immunol. 2020 Apr 03;11:489
pubmed: 32318059
Clin J Am Soc Nephrol. 2021 Sep;16(9):1318-1327
pubmed: 34135023
Clin J Am Soc Nephrol. 2012 Oct;7(10):1692-700
pubmed: 22879433
Cancer. 2010 Sep 1;116(17):4063-8
pubmed: 20564156
Bone Marrow Transplant. 2015 Dec;50(12):1557-62
pubmed: 26301965
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508
pubmed: 19218475
Bone Marrow Transplant. 2021 Aug;56(8):1805-1817
pubmed: 33875812
J Natl Cancer Inst. 2019 Jul 1;111(7):727-736
pubmed: 30423160
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1
pubmed: 25529383
Br J Haematol. 2020 Sep;190(6):822-836
pubmed: 32133623
Blood. 2011 Aug 11;118(6):1452-62
pubmed: 21596850
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1228-32
pubmed: 16682132
Bone Marrow Transplant. 2010 Sep;45(9):1427-34
pubmed: 20062103
Curr Opin Crit Care. 2019 Dec;25(6):531-538
pubmed: 31524721
Bone Marrow Transplant. 2013 Feb;48(2):284-93
pubmed: 22825425
Bone Marrow Transplant. 2011 Nov;46(11):1399-408
pubmed: 21383682
Haematologica. 2007 Jan;92(1):95-100
pubmed: 17229640
Bone Marrow Transplant. 2016 Jun;51(6):786-92
pubmed: 26901709

Auteurs

Andreea Andronesi (A)

Department of Nephrology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Bogdan Sorohan (B)

Department of Nephrology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Andreea Burcea (A)

Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Lavinia Lipan (L)

Bone Marrow Transplant Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Cristina Stanescu (C)

Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Oana Craciun (O)

Bone Marrow Transplant Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Laura Stefan (L)

Bone Marrow Transplant Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Adela Ranete (A)

Bone Marrow Transplant Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Zsofia Varady (Z)

Bone Marrow Transplant Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Oana Ungureanu (O)

Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Gabriela Lupusoru (G)

Department of Nephrology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Gabriela Agrigoroaei (G)

Department of Nephrology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Danut Andronesi (D)

Department of General Surgery and Liver Transplant, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Luminita Iliuta (L)

Department of Biostatistics, Marketing and Medical Technology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Bogdan Obrisca (B)

Department of Nephrology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Alina Tanase (A)

Bone Marrow Transplant Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

Classifications MeSH